AIRLINK 72.13 Increased By ▲ 2.93 (4.23%)
BOP 5.04 Increased By ▲ 0.14 (2.86%)
CNERGY 4.32 Increased By ▲ 0.06 (1.41%)
DFML 31.40 Increased By ▲ 0.15 (0.48%)
DGKC 80.37 Increased By ▲ 3.12 (4.04%)
FCCL 21.03 Increased By ▲ 1.03 (5.15%)
FFBL 34.82 Decreased By ▼ -0.18 (-0.51%)
FFL 9.17 Increased By ▲ 0.05 (0.55%)
GGL 9.81 Increased By ▲ 0.01 (0.1%)
HBL 113.40 Increased By ▲ 0.64 (0.57%)
HUBC 134.20 Increased By ▲ 1.16 (0.87%)
HUMNL 7.02 Increased By ▲ 0.07 (1.01%)
KEL 4.35 Increased By ▲ 0.12 (2.84%)
KOSM 4.35 Increased By ▲ 0.10 (2.35%)
MLCF 37.20 Increased By ▲ 0.60 (1.64%)
OGDC 135.40 Increased By ▲ 2.53 (1.9%)
PAEL 23.69 Increased By ▲ 1.05 (4.64%)
PIAA 24.60 Increased By ▲ 0.40 (1.65%)
PIBTL 6.52 Increased By ▲ 0.06 (0.93%)
PPL 120.40 Increased By ▲ 4.10 (3.53%)
PRL 26.33 Increased By ▲ 0.43 (1.66%)
PTC 13.20 Increased By ▲ 0.12 (0.92%)
SEARL 52.40 Increased By ▲ 0.40 (0.77%)
SNGP 71.40 Increased By ▲ 3.80 (5.62%)
SSGC 10.60 Increased By ▲ 0.06 (0.57%)
TELE 8.40 Increased By ▲ 0.12 (1.45%)
TPLP 11.11 Increased By ▲ 0.31 (2.87%)
TRG 60.51 Increased By ▲ 1.22 (2.06%)
UNITY 25.21 Increased By ▲ 0.08 (0.32%)
WTL 1.27 No Change ▼ 0.00 (0%)
BR100 7,490 Increased By 81.2 (1.1%)
BR30 24,512 Increased By 475.5 (1.98%)
KSE100 71,504 Increased By 837.6 (1.19%)
KSE30 23,444 Increased By 220 (0.95%)

ISLAMABAD: The Australian High Commissioner to Pakistan, Dr Geoffrey Shaw took to twitter on Thursday to welcome COVAX initial vaccine allocation to Pakistan.

“I welcome COVAX announcement of initial vaccine allocations, including 17.2 million doses for Pakistan. Australia has contributed $80 million to COVAX.”

“We will continue to advocate for equitable access to safe and effective COVID-19 vaccines,” High Commissioner added.

Australia’s contribution to COVAX Facility’s Advance Market Commitment (AMC) will provide safe and effective vaccines to the world’s most vulnerable populations – including Pakistan.The COVAX AMC works to pool purchasing power and risk, to prepare the most diverse portfolio of COVID-19 vaccines, fast track manufacturing, and ensure developing countries are not excluded from accessing vaccines due to price constraints.—PR

Copyright Business Recorder, 2021

Comments

Comments are closed.